|
Case
|
Sex
|
Age
|
Primary Site
|
Metastatic Sites
|
Metastatic Sites and Doses (Total Dose (Dose Per Rraction))
|
Failure Sites
|
Time to Progression (Months)
|
|
1
|
M
|
18
|
Hand
|
1. T9 vertebra
2. Axillary lymph nodes (LN)
|
1. Axilla: 50.4 Gy (1.8)
2. T9: 45 Gy (1.8)
|
Liver
Para-aortic LN
Calvarium
Sternum
|
15.5
|
|
2
|
F
|
13
|
Foot
|
1. Popliteal LN
2. Inguinal LN
3. Iliac LN
4. Paraaortic LN
5. Breast (surgically resected)
6. Bone (axial skeleton)
|
1. Popliteal LN: 41.4 Gy (1.8)
2. Inguinal LN: 36 Gy (1.8)
3. Iliac LN: 36 Gy (1.8)
4. Paraaortic LN: 36 Gy (1.8)
|
Abdominal wall
Breast
Brain
Spine
|
2
|
|
3
|
M
|
12
|
Naso-pharynx
|
1. Lungs
|
1. Whole lung – 15 Gy (1.5)
|
none
|
n/a (died from AML, no evidence of RMS at death 14 months post-RT)
|
|
4
|
F
|
16
|
Hand
|
1. Axillary LN
2. Internal mammary LN
|
1. Axillary LN: 45 Gy (1.8)
2. IMC: 45 Gy (1.8)
|
none
|
n/a (no evidence of disease after 88 months)
|
|
5
|
F
|
13
|
Chest wall
|
1. Mediastinal LN
2. Lungs
3. Breast
|
1. Mediastinal LN: 41.4 Gy (1.8)
2. Whole lung: 15 Gy (1.5)
|
Flank (contralateral)
Extensive abdomino-peritoneal disease
|
6
|
